Considering the multiple and complex effects of calycosin (such as anti-inflammation, anti-apoptosis and antioxidation), it is necessary to investigate the molecular mechanism underlying the role of calycosin in orchestrating the NLRP3-IL-33/ST2 signaling, which finally contributes to the development of IBD. The gene discussed is IL33; the disease is inflammatory bowel disease.